By reversing Angiotensin II (Ang II)-mediated systemic inflammation by increasing the impact of cardioprotective Ang(1–7), ACE2 alleviated pulmonary arterial hypertension (PAH) and Acute Respiratory Distress Syndrome (ARDS)-induced systemic inflammation [65,66]. Here, ACE2 is linked to pulmonary arterial hypertension.